Highlights of the 15th Japan Bioanalysis Forum Symposium.

Autor: Niwa M; Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Kyoto, Japan., Arakawa T; Clinical Pharmacology and Bioanalytics, Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, Japan., Arai K; Bioanalysis Department, Mediford Corporation, Itabashi-ku, Tokyo, Japan., Koyama N; Tokushima Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan., Hara H; RW Bioanalysis Consulting, Bottmingen, Switzerland., Hata K; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Osaka, Japan., Hashimoto M; Department of Biometrics, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Osaka, Osaka, Japan., Shimada E; Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Mishima, Osaka, Japan., Shimizu H; DMPK Research Laboratories, Research Division, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Kanagawa, Japan., Takamatsu Y; Center of Excellence for Drug Metabolism, Pharmacokinetics and Modeling, Preclinical and Translational Sciences, Research, Takeda Pharmaceutical Co., Ltd., Fujisawa, Kanagawa, Japan., Uchiyama H; R&D Division, Towa Pharmaceutical Co., Ltd., Settsu, Osaka, Japan., Yamaguchi T; Osaka Laboratory, Sumika Chemical Analysis Service, Ltd., Osaka, Osaka, Japan., Yamamoto K; Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd., Kainan, Wakayama, Japan., Kakehi M; Center of Excellence for Drug Metabolism, Pharmacokinetics and Modeling, Preclinical and Translational Sciences, Research, Takeda Pharmaceutical Co., Ltd., Fujisawa, Kanagawa, Japan., Moriya Y; Center of Excellence for Drug Metabolism, Pharmacokinetics and Modeling, Preclinical and Translational Sciences, Research, Takeda Pharmaceutical Co., Ltd., Fujisawa, Kanagawa, Japan., Kurisu H; Clinical Pharmacology and Bioanalytics, Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, Japan., Nagaya H; Synplogen Co., Ltd., Kobe, Hyogo, Japan., Nakazawa T; R&D Division, Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan., Noguchi S; Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd., Kagoshima, Kagoshima, Japan., Oda Y; Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan., Okamoto H; R&D Division, Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan., Uchihashi S; Drug Development Research Laboratories, Maruho Co., Ltd., Osaka, Osaka, Japan.
Jazyk: angličtina
Zdroj: Bioanalysis [Bioanalysis] 2024 Sep 12, pp. 1-6. Date of Electronic Publication: 2024 Sep 12.
DOI: 10.1080/17576180.2024.2395715
Abstrakt: The 15th Japan Bioanalysis Forum (JBF) Symposium was held in Kyoto, Japan, between 5 and 7 February 2024. The conference theme, 'Toward the new world - Science as a universal endeavor' indicated that universal discussion based on science is making a basis of regulatory and analytical sciences, now internationally harmonized. The symposium discussed a wide range of topics, including ICH M10, quantitative PCR, immunogenicity, peptide LC-MS, e-notebooks, artificial intelligence, reliability standards, carrier development, inviting domestic and overseas experts. Approximately 360 attendees from various fields, including pharmaceutical companies, contract research organizations, academia and regulators, gathered in person or online.
Databáze: MEDLINE